+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aerie Pharmaceuticals - logo

Aerie Pharmaceuticals is a company that focuses on the development and commercialization of therapies for the treatment of glaucoma and other eye diseases. The National Eye Institute expects the number of people in the United States suffering from glaucoma to reach 4.3 million by 2030. Aerie was founded in 2005 and went in public in 2013, raising $67 million in its IPO. Its product candidates include Rhopressa and Roclatan. The company is headquartered in Irvine, California.

Ophthalmic Therapeutic Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Ophthalmic Therapeutic Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 93 Pages
  • Global
From
Glaucoma Pharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Glaucoma Pharmaceutical Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 79 Pages
  • Global
From
Nystagmus Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Nystagmus Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 83 Pages
  • Global
From
Ophthalmology Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Ophthalmology Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 95 Pages
  • Global
From
Age-Related Vision Dysfunction - Market Insights, Epidemiology, and Market Forecast - 2030 - Product Thumbnail Image

Age-Related Vision Dysfunction - Market Insights, Epidemiology, and Market Forecast - 2030

  • Report
  • May 2021
  • 250 Pages
  • Global
From
Global Fuchs Dystrophy - Pipeline Insight, 2022 - Product Thumbnail Image

Global Fuchs Dystrophy - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
Glaucoma - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Glaucoma - Global Drug Forecast and Market Analysis to 2030

  • Report
  • January 2022
  • 160 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Controlled Release Drug Delivery Global Market Report 2024 - Product Thumbnail Image

Controlled Release Drug Delivery Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures - Product Thumbnail Image

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

  • Report
  • May 2019
  • 385 Pages
  • Global
From
Angina Pectoris Drugs Global Market Report 2024 - Product Thumbnail Image

Angina Pectoris Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Netarsudil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Netarsudil Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • April 2022
  • 577 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Aerie Pharmaceuticals Inc (AERI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Aerie Pharmaceuticals Inc (AERI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • May 2023
  • 85 Pages
From
Aerie Pharmaceuticals Inc (AERI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Aerie Pharmaceuticals Inc (AERI) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2022
  • 52 Pages
From
Loading Indicator